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The adrenal gland has been historically an object of interest
and scientific curiosity. This is also due to its very hetero-
geneous structure, number of hormones, complex neural
innervation, and multiple and different physiological func-
tions. The adrenal gland also entails an outstanding example
of paracrine interactions occurring between histogenetically
different tissues as the cortex and the medulla.
This special issue is a great opportunity for the reader to
learn the latest and emerging findings on the pathophysiol-
ogy, diagnosis, and treatment of the adrenal glands disorders.
The issue provides a variety of excellent articles covering a
broad and contemporary spectrum of aspects of the diseases
of the adrenal gland.
Of particular interest and novelty is the interplay between
hormones of the adrenal glands and other organs, such as
the adipose tissue, the endothelium, the bone, and even the
brain. In addition to the well-established effects on lipid and
glucose metabolism, the hormones of the adrenal glands
display a fascinating cross talk with the adipose tissue [1–
3]. The interaction between the adrenals and adipokines is
extensively discussed by A. Y. Kargi and G. Iacobellis in a
comprehensive and updated review paper. The potential of
the fat depot surrounding the adrenal tumors to act like
a brown adipose tissue (BAT) is a rapidly emerging topic
that will certainly deserve further attention and investigation
[4]. Interestingly the authors provided a theoretical basis
for potential future pharmacological interventions aimed at
adrenal hormone targets in the adipose tissue.
Primary aldosteronism is the most common endocrine
cause of arterial hypertension. It can cause excess damage
to the organs that are target of hypertension and higher
cardiometabolic risk [5]. This contention was supported by
previous experimental data obtained byKarlWeber’s group in
rats infused with aldosterone, which exhibited hypercalciuria
and raised parathyroid hormone (PTH) levels [6], and,
more importantly, by findings in patients with aldosterone-
producing adenoma who also showed elevated serum PTH
levels that were then normalized by adrenalectomy [7]. The
effect of the adrenal hormones on bone metabolism in
patients with primary aldosteronism is nicely addressed by
L. Petramala et al. The authors sought to test the hypothesis
that hyperaldosteronism may influence mineral homeostasis
through higher urinary calcium excretion leading eventually
to secondary hyperparathyroidism. Of further interest, G.
Mazzocchi et al. showed that PTH stimulates aldosterone
secretion in a concentration-dependentmanner [8], a finding
that was complemented by the demonstration of the miner-
alocorticoid receptor in the human parathyroid cells [9]. It is
well established that a substantial amount of sodium is bound
to proteoglycans of bone, connective tissue, and cartilage
and that the osmotic force created by the high sodium
concentration maintains the high water content in the latter
tissue, allowing it to withstand high pressures during exercise
[10]. In this special issue P. Alonso et al. further expand
on the relationships between the adrenal gland and the
skeleton by showing a reduction in the bone mineral density
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in children with congenital adrenal hyperplasia when bone
age rather than chronological age is considered. Altogether
these findings further enhance the multitargeting effects
of hormones like cortisol and aldosterone and open new
avenues for the understanding of the interactions between
adrenal and other hormones and tissues originally thought
to be totally unrelated. These evidences are rapidly changing
the paradigm that hormonal systems work independently.
V. Salpietro et al. extensively discussed the potential neu-
rological manifestations in children with adrenal dysfunction
and the compelling need for an early diagnosis.
The causative and prognostic role of neoangiogenesis in
patients with pheochromocytoma is analyzed by M. Bialas
and colleagues. Neoangiogenesis was evaluated by assessing
microvessel density (MVD) and the expression of vascular
endothelial growth factors (VEGFs). The study showed that
MVD is not able to differentiate between benign and malig-
nant pheochromocytomas. However, the authors proposed
that high MVD could be a promising factor for antiangio-
genic therapy in malignant cases of pheochromocytoma.
Accurate genetic testing of adrenal glands tumors, such
as pheochromocytomas, is the topic of interesting articles by
D. A. Rowbotham et al. and R. Martins and M. J. Bugalho.
Promising results suggest that mutations in the von Hippel-
Lindau (VHL) gene elongin BC protein complex could be
important factor for the development of pheochromocy-
tomas.
Genetic analysis is certainly a key factor, but how do
we manage cardiovascular disease prevention in adrenal
diseases? Cushing’s syndrome and even subclinical hypercor-
tisolism are associated with higher cardiovascular risk [11].
But do we have effective tools to predict and possibly prevent
this risk? Y.-F. Wang et al. stressed out the need of using
the congestive heart failure (C), hypertension (H), age (A),
diabetes (D), and stroke (S), the CHADS2 score, to predict
major cardiovascular events in patients affected by Cushing’s
syndrome. Perhaps, other biomarkers, such as imaging of
organ-specific fat depot, will emerge for the cardiovascular
risk stratification in the adrenal gland diseases [11].
Finally, the best surgical approach and treatment for
different clinical conditions and adrenal tumors, such as
adrenal benign tumors, incidentalomas, ormetastatic adrenal
tumors, are also object of discussion in this special issue.
There is a consensus that laparoscopic adrenalectomy should
be considered as the first choice treatment for the resection
of adrenal benign tumors, as suggested by S. Chuan-yu
et al, whereas the role of laparoscopic surgery in small
incidentaloma is still controversial, as nicely discussed by M.
Pędziwiatr et al. The surgical management of adrenal tumors
is object of recent debate and investigation. A recent and
large multinational observational retrospective population-
based study suggested that adrenal-sparing surgery should
be the surgical approach of choice for multiple endocrine
neoplasia type 2-related phaeochromocytoma to reduce
the Addisonian-like complications and consequent lifelong
dependency on steroids [12].
In conclusion, the interest in the adrenal gland is
now encompassing a broader audience of physicians and
researchers.This special issue is aimed at engaging the reader
in an exciting reading of the new insights on the adrenal
glands and related disorders.
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